A NEW TREATMENT OPTION
What is it?
Supportive Oligonucleotide Technique (SOT) is a treatment against a number of viruses, chronic diseases, as well as Lyme bacterial infections and co-infections.
SOT works by creating a shutoff “key” that fits into a chosen “lock” portion of a pathogen or cancer cell.
The “lock” is a specific section of DNA that normally controls an important function of the cancer cell or pathogen.
The “key” binds to the “lock” and blocks the function and the replication of the cell – thereby killing the cancer cell or pathogen, and preventing its replication.
If a patient has multiple active infections, multiple SOT treatments will be needed for each infection.
How does it work?
SOT therapy utilizes molecular building blocks (mRNA) that are found naturally in the patient’s body.
Nucleotides are the molecules that form the structure of DNA and RNA.
SOT therapy creates an oligonucleotide which is complementary to a specific sequence for each gene.
It is designed to bind to this gene’s counterpart (mirror image) in the body, thus blocking its function.
It blocks a specific target at a very high rate – stopping the expression and transcription of a specific gene.
(Important side note: SOT is not a drug and there is no gene manipulation).
SOT terminates gene replication sequences, thus eradicating pathogens or cancerous cells from the body and preventing future lifecycles of these cells.
This therapy is tailored to each patient – and against the most active target for that individual. The SOT is complementary to a specific target inside cancer cells, viruses and Lyme bacteria. Therefore, it is highly specific to these only and will only work for the patient that is was made for.
What does it do?
SOT induces rapid apoptosis in circulating tumor cells (CTCs), circulating cancer stem cells (CSCs), primary tumor cells, and metastatic tumors. In addition, it is able to cross the blood-brain barrier.
Currently, the SOT is available for the following Lyme species and co-infections: Borrelia mayonii – Borrelia burgdorferi – Borrelia garinii – Borrelia bissettii – Borrelia bavariensis – Borrelia miyamotoi – Candidatus Borrelia tachyglossi – Borrelia valaisiana – Borrelia afzelii – Borrelia finlandensis – Borrelia recurrentis – Bartonella henselae – Bartonella bacilliformis – Bartonella vinsonii – Bartonella quintana – Babesia microti – Babesia bigemina – Babesia divergens – Babesia duncani – Babesia bovis
The following viruses:
– EBV (Epstein Barr Virus)
– CMV (cytomegalovirus)
– Coxsackie virus (Types A & B)
– VZV (Varicella Zoster virus (chicken pox, shingles))
– HHV1/HSV1 (oral herpes virus) – HHV2/HSV2 (genital herpes virus) – HHV6 (Types A & B) (human herpes virus 6)
– HPV (16/18) (human papillomavirus) – HPV (6/11) (human papillomavirus)
– HTLV1 (Human T-cell lymphotropic Virus)
– HBV (Hepatitis B Virus)
– HCV (Hepatitis C Virus)
– HIV (Human Immunodeficiency Virus)
Side Effects
Because it is highly compatible with the patient, the side effects are usually minimal. Potential side effects may include headaches, body aches, general malaise, sweating, diarrhea, cough, fever, (generally <101°F), and mild to moderate flu-like symptoms.
These symptoms resolve within 24-48 hours or up to a week.
Herxheimer reactions (also known as “die-off”) can occur.
“Herx” reactions, can include fatigue, body aches, and headache.
Patients who have gone through treatment will often say that symptoms can get worse before it gets better.
Procedure
1 – The patient’s blood is drawn.
2 – The blood is sent to RGCC laboratory.
3 – RGCC lab identifies the main genetic sequence of the target replication genes, then creates a complementary oligonucleotide sequence to block replication.
4 – RGCC ships the blood back to the patient’s clinic, where it is infused intravenously (usually takes about an hour).
Intravenous antihistamines and low dose steroids are given immediately prior to SOT administration in order to lessen the (rare) chance of allergic reaction and tighten the vein walls to minimize leaking of SOT.
SOT may be repeated up to 3x per year if needed.
With each round of SOT it is recommended to retest for the presence of pathogens.
At some point the infection may be completely eradicated or remain stable in remission.